Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: An institutional experience

American Surgeon

Volumn 66, Issue 4, 2000, Pages 378-386

  Chao, Celia ^a   Hoffman, John P ^a,b   Ross, Eric A ^a   Torosian, Michael H ^a   Eisenberg, Burton L ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; MITOMYCIN C; PACLITAXEL;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME; VASCULAR SURGERY;

ADENOCARCINOMA; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PANCREATECTOMY; PANCREATIC NEOPLASMS; PATIENT SELECTION; PHILADELPHIA; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034128217     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1999. CA Cancer J Clin 1999;44:8-34.
2. Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose radiation alone, moderate dose radiation, and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705-10.
3. Pendurthi TK, Hoffman JP, Ross E, Johnson DE, Eisenberg BL. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. Am Surg 1998;64: 686-92.
4. Hoffman JP, Weese JL, Solin LJ, et al. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma. Am Surg 1993;59:772-81.
5. Hoffman JP, Lipsitz S, Pisansky T, et al. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group study. J Clin Oncol 1998;16: 317-23.
6. Hoffman JP, McGinn CJ. Szarka C, et al. A Phase I study of preoperative gemcitabine (GEM) with radiation therapy (RT) followed by postoperative GEM for patients with localized, resectable pancreatic adenocarcinoma (PAC). Proc ASCO 1998;17: A1090.
7. Hoffman JP, Cooper HS, Young NA, Pendurthi TK. Preoperative chemotherapy or chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater. J Hepatobil Pancreat Surg 1998;5:251-4.
8. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemo-radiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992;127:1335-9.
9. Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AR, Engstrom PF, Litwin S, Kowalyshyn MJ, Eisenberg BL. Neoadjuvant chemoradiation in pancreatic and duodenal cancer: A phase II study. Cancer 1993;72:2124-33.
10. Fortner JG. Surgical principles for pancreatic cancer: Regional total and subtotal pancreatectomy. Cancer 1981;47:1712-8.
11. Jones BA, Langer B, Taylor BR, Girotti M. Periampullary tumors: Which ones should be resected? Am J Surg 1985;149: 46-52.
12. Moosa AR. Reoperation for pancreatic cancer. Arch Surg 1979;114:502-4.
13. Hashimi H, Sabanathan S. Second look operation in managing carcinoma of the pancreas and periampullary region. Surg Gynecol Obstet 1989;168:224-6.
14. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer 1980;46:1945-9.
15. Robinson EK, Lee JE, Lowy AM, et al. Reoperative pancreaticoduodenectomy for periampullary carcinoma. Am J Surg 1996;172:432-8.
16. Johnstone PAS, Sindelar WF. Radical reoperation for advanced pancreatic carcinoma. J Surg Oncol 1996;61:7-13.
17. Sohn TA, Lillemoe KD, Cameron JL, et al. Reexploration for periampullary carcinoma: Resectability, perioperative results, pathology, and long-term outcome. Ann Surg 1999;229:393-400.
18. Todd KE, Gloor B, Lane JS, et al. Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole. J Gastrointest Surg 1998;2:159-66.
19. McGuire GE, Pitt HA, Lillemoe KD, et al. Reoperative surgery for periampullay adenocarcinoma. Arch Surg 1991;126: 1205-12.
20. Kamthan AG, Morris JC, Dalton J, et al. Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 1997;15:2920-7.
21. White R, Lee C, Anscher M, et al. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 1999;6:38-45.
22. Hoffman JP. Cancer of the exocrine pancreas in cancer surgery. In: Harvey JC, Beattie EJ, eds. Cancer Surgery. Philadelphia: W.B. Saunders Company, 1996, pp 125-33.
23. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of pancreas: 201 patients. Ann Surg 1995;221:721-33.
24. Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy: Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996;223:718-28.
25. Staley CA, Lee JE, Cleary KR, et al. Preoperative chemoradiation, pancreatic duodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118-25.
26. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280:1747-51.
27. Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 1998;228:429-38.